Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Tavridou

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Drug Metabolism and Personalized Therapy|October 3, 2014
No effect of CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) on lipid-lowering response to statins in Greek patients with primary hypercholesterolemiaGeorgia Ragia, Vana Kolovou, Anna Tavridou, et al.
European Journal of Pharmacology|March 21, 2006
Pharmacological characterization in vitro of EP2306 and EP2302, potent inhibitors of squalene synthase and lipid biosynthesisAnna Tavridou, Loukas Kaklamanis, George Megaritis, et al.
European Journal of Haematology|February 18, 2009
Oxidised low-density lipoprotein and arterial function in beta-thalassemia majorDimitrios A Stakos, Anna Tavridou, Dimitrios Margaritis, et al.
Drug Metabolism and Personalized Therapy|December 19, 2017
Role of CYP4F2, CYP2C19, and CYP1A2 polymorphisms on acenocoumarol pharmacogenomic algorithm accuracy improvement in the Greek population: need for sub-phenotype analysisGeorgia Ragia, Ioanna-Maria Karantza, Eleni Kelli-Kota, et al.
Annals of Human Genetics|October 16, 2012
Exploring genomic structure differences and similarities between the Greek and European HapMap populations: implications for association studiesVasileios Stathias, Georgios R Sotiris, Iordanis Karagiannidis, et al.
European Heart Journal|August 21, 2025
Pharmacotherapy of cardiovascular diseases from herbs and pills to nucleic acidsUlf Landmesser, Thomas Thum, Lale Tokgözoğlu, et al.
The New England Journal of Medicine|November 21, 2013
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumonTalitha I Verhoef, Georgia Ragia, Anthonius de Boer, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Drug Metabolism and Personalized Therapy|October 3, 2014
No effect of CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) on lipid-lowering response to statins in Greek patients with primary hypercholesterolemiaGeorgia Ragia, Vana Kolovou, Anna Tavridou, et al.
European Journal of Pharmacology|March 21, 2006
Pharmacological characterization in vitro of EP2306 and EP2302, potent inhibitors of squalene synthase and lipid biosynthesisAnna Tavridou, Loukas Kaklamanis, George Megaritis, et al.
European Journal of Haematology|February 18, 2009
Oxidised low-density lipoprotein and arterial function in beta-thalassemia majorDimitrios A Stakos, Anna Tavridou, Dimitrios Margaritis, et al.
Drug Metabolism and Personalized Therapy|December 19, 2017
Role of CYP4F2, CYP2C19, and CYP1A2 polymorphisms on acenocoumarol pharmacogenomic algorithm accuracy improvement in the Greek population: need for sub-phenotype analysisGeorgia Ragia, Ioanna-Maria Karantza, Eleni Kelli-Kota, et al.
Annals of Human Genetics|October 16, 2012
Exploring genomic structure differences and similarities between the Greek and European HapMap populations: implications for association studiesVasileios Stathias, Georgios R Sotiris, Iordanis Karagiannidis, et al.
European Heart Journal|August 21, 2025
Pharmacotherapy of cardiovascular diseases from herbs and pills to nucleic acidsUlf Landmesser, Thomas Thum, Lale Tokgözoğlu, et al.
The New England Journal of Medicine|November 21, 2013
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumonTalitha I Verhoef, Georgia Ragia, Anthonius de Boer, et al.
Pageof 5